Glaukos' revenue growth is the market's focus due to its unprofitability. The 88% share price gain is solid, not standout. Market sentiment is lukewarm, hinting at potential stronger growth trends. Recent sentiment is positive due to strong share price momentum.
Glaukos' stock carries risk due to losses and high debt, despite cash reserves. The absence of EBIT level profits and free cash flow make sustainability questionable. Investors should proceed with caution.
$ProShares Ultra納斯達克生物科(BIB.US)$was climbing 1.5%. $SciSparc(SPRC.US)$rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing. $Glaukos(GKOS.US)$gained 6% after We...
Gainers: •$Canoo(GOEV.US)$+71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart) •$Aldeyra Therapeutics(ALDX.US)$+14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial) •$西港燃料(WPRT.US)$+10.9% (awarded 38 mln program) •$Greenwich LifeSciences(GLSI.US)$+5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
Glaukos股票討論區
PDUFA Update…
$Arcutis Biotherapeutics(ARQT.US)$ : Approved 12/15
• ZORYVE® (Roflumilast foam 0.3%)
⇒ topical foam
⇒ PDUFA: 12/16/23
⇒ NDA
⇒ Seborrheic dermatitis
$默沙東(MRK.US)$ : Approved 12/15
• KEYTRUDA (pembrolizumab) + Padcev (enfortumab vedotin-ejfv)
⇒ IV injection
⇒ PDUFA: 05/09/24
⇒ sBLA
⇒ Urothelial cancer
$Glaukos(GKOS.US)$ : Approved 12/14
• iDose® TR (travoprost)
⇒ intracameral implant
⇒ PDUFA: 12/22/23
⇒ NDA
⇒ Glaucoma
$默沙東(MRK.US)$ : Approved ...
PDUFA Events for December 2023
Join us to connect and share, and to get info fast!
$CRISPR Therapeutics(CRSP.US)$$福泰製藥(VRTX.US)$$OptiNose(OPTN.US)$$Arcutis Biotherapeutics(ARQT.US)$$Calliditas Therapeutics(CALT.US)$$bluebird bio(BLUE.US)$$Glaukos(GKOS.US)$$Ionis Pharmaceuticals(IONS.US)$$安進(AMGN.US)$$默沙東(MRK.US)$
Let’s see if this bounces
im seeing some decent chart upside here
thoughts?
Health Care Sector Update for 08/24/2022: SPRC,GKOS,BCDA
$SciSparc(SPRC.US)$ rallied Wednesday, climbing over 20%, after the Israeli pharmaceuticals company said the psychedelic-based MEAI drug candidate developed with Canadian collaborator Clearmind Medicine produced a significant decrease in coccaine craving in rats compared to those in a non-treated control group during pre-clinical testing.
$Glaukos(GKOS.US)$ gained 6% after We...
專欄Today's pre-market stock movers: PTON, PEP, NVAX, GPS and more
• $Canoo(GOEV.US)$ +71.3% (receives purchase order of 4500 Canoo Electric Delivery Vehicles from Walmart)
• $Aldeyra Therapeutics(ALDX.US)$ +14.1% (achieved primary endpoints in dry eye disease chamber crossover clinical trial)
• $西港燃料(WPRT.US)$ +10.9% (awarded 38 mln program)
• $Greenwich LifeSciences(GLSI.US)$ +5.9% (FDA has removed the clinical hold permitting the Flamingo-01 Phase III clinical trial to proceed...
暫無評論